Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy. [electronic resource]
- Drugs of today (Barcelona, Spain : 1998) Dec 2019
- 727-734 p. digital
Publication Type: Journal Article
1699-3993
10.1358/dot.2019.55.12.3078389 doi
Amyloid Neuropathies, Familial--complications Benzoxazoles--therapeutic use Cardiomyopathies--complications Humans Prealbumin